Insider Transactions in Q1 2023 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Niro Ph.D Ramachandran Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,945
-1.09%
|
$13,615
$7.69 P/Share
|
|
Mar 23
2023
|
Brian Mc Kelligon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,437
-4.65%
|
$52,059
$7.69 P/Share
|
|
Mar 23
2023
|
Frederic Pla Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,945
-4.58%
|
$13,615
$7.69 P/Share
|
|
Mar 20
2023
|
Jennifer Kamocsay General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+50.0%
|
-
|
|
Mar 20
2023
|
John Frederick Ek CFO |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+50.0%
|
-
|
|
Mar 14
2023
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.52%
|
$45,000
$9.53 P/Share
|
|
Mar 14
2023
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.94%
|
$0
$0.3 P/Share
|
|
Feb 23
2023
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+11.16%
|
-
|
|
Feb 23
2023
|
Frederic Pla Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+32.0%
|
-
|
|
Feb 23
2023
|
Ehab El Gabry Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+50.0%
|
-
|
|
Feb 23
2023
|
Marilee Moy CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Feb 23
2023
|
Brian Mc Kelligon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+33.33%
|
-
|
|
Feb 15
2023
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,000
+17.83%
|
$0
$0.91 P/Share
|